ArticleMolecular biology reports2026
Genomic characterization of CTX-M-15-producing Klebsiella pneumoniae ST709-KL9 from neonatal bacteraemia in eastern India.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundKlebsiella pneumoniae, a WHO-designated critical-priority pathogen, is a predominant cause of neonatal bacteraemia in India, associated with high morbidity and mortality. The global emergence and spread of high-risk clones, combined with convergence of antimicrobial resistance (AMR) and virulence traits, underscores the need for close genomic surveillance. This study presents AMR and virulence traits of K. pneumoniae ST709-KL9 strain isolated from neonatal blood in West Bengal, India. METHODS AND
resultsThe blood isolate from a 10-day-old neonate (November 2021) underwent identification, antimicrobial susceptibility testing, hypermucoviscosity assessment, and whole genome sequence analysis. The 5.47 Mb genome comprised one chromosome (5.2 Mb) and three MOB-suite-predicted plasmid-associated contigs [IncFIIK (59.4 kb), IncHI1B: IncFIB (219.7 kb), IncR (13.2 kb)]. Core findings included ST709 (single-locus variant of ST15), KL9/O2 capsular-type, and multidrug-resistant (MDR) phenotype (Ceftriaxone
conclusionsThis single-isolate genomic study is the first report of bla
Indexed as
Identifiers
42804020What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.